Robotic Versus Laparoscopic Medial Arcuate Ligament Release

Overview

About this study

The prupos of this study is to determine the long-term outcomes and symptoms resolution in patients who undergo robotic versus laparoscopic medial arcuate ligament release. Also, to study the intraoperative outcomes (operative time, blood loss, and conversion to open approach) and postoperative outcomes (including length of hospital stay and postoperative complications) of patients who undergo laparoscopic versus robotic median arcuate ligament release. We aim to determine if the median arcuate ligament release using a robotic approach provides optimal outcomes comparable to the laparoscopic median arcuate ligament release.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • > 18 years of age with ability to provide informed consent

Exclusion Criteria:

  • Previous median arcuate ligament release, pregnancy, and BMI > 35

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 12/11/23. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Houssam Farres, M.D.

Open for enrollment

Contact information:

Houssam Farres M.D.

(904) 953-2077

Farres.Houssam@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20571171

Mayo Clinic Footer